Resources

• Restricted Anti-infective Drugs – Adult & Pediatric

  08/25/26

  Adult/Peds: Adult, Pediatric*    

  Keywords: Restricted anti-infective drugs may be approved by the ID consult services or by the Carolina Antimicrobial Stewardship Program (CASP). Restricted anti-infectives initiated by the ID medicine service (MDK) do not require approval.

  ---

• Staphylococcus aureus Bacteremia Management

  08/25/26

    Organism: Bacteria  

  Keywords: MRSA, MSSA, Staphylococcus, Staphylococcus aureus, S.aureus, Blood stream, s aureus

  ---

• Gram-Positive Rapid Blood Culture Guideline – Adult & Pediatric

  08/14/26

  Adult/Peds: Adult    

  Keywords: The purpose of this protocol is to describe the process whereby a pharmacist recommends targeted antibiotic therapy for Gram-positive bacteremia based on rapid laboratory testing.

  ---

• Candida Bloodstream Infection Management

  06/15/26

  Adult/Peds: Adult, Pediatric*  Organism: Fungi  

  Keywords: candida, candidemia, C. glabrata, Bloodstream, antifungal, azole, micafungin

  ---

• Urinary Tract Infection (UTI) Guideline – Adolescents & Adults

  06/15/26

  Adult/Peds: Adult, Pediatric*    

  Keywords: UTI, cystitis, pyelonephritis, urinary tract infection, urinary, asymptomatic bacteriuria, catheter associated urinary tract infection, candida Uti, candiduria

  ---

• Vancomycin-resistant Enterococcus (VRE) Treatment

  06/15/26

    Organism: Bacteria  

  Keywords: VRE, vancomycin resistant, enterococcus, e. faecalis, e. faecium, daptomycin, Enterococcus

  ---

• Management of Pelvic/Sacral Osteomyelitis in Adults with or without Skin and Soft Tissue Infections

  06/01/26

  Adult/Peds: Adult    

  Keywords: There is growing evidence that prolonged IV antibiotic treatment for osteomyelitis (OM) in the absence of a plan for wound coverage does not provide any benefit and may be associated with some risk (i.e., development of multidrug-resistant organisms). This guideline aims to streamline and optimize evaluation and management of patients with pelvic or sacral osteomyelitis while acknowledging that these are complex patients who require individualized care and for whom this management plan may not be appropriate.

  ---

• Community-onset Diarrhea Pathway

  05/15/26

  Adult/Peds: Adult    

  Keywords:

  ---

• Gram-negative Bacteremia Treatment Pathway

  05/15/26

  Adult/Peds: Adult  Organism: Bacteria  

  Keywords: This treatment pathway is intended for patients with uncomplicated Gram-negative bacteremia with a known pathogen and pending microbiological susceptibility testing results.

  ---

• Antimicrobial Primary Prophylaxis for Children with Hematologic and Oncologic Malignancies

  04/17/26

  Adult/Peds: Pediatric*    

  Keywords:

  ---

• Best Practices for Antimicrobial Duration of Therapy for Common Infections

  02/28/26

  Adult/Peds: Adult, Pediatric*    

  Keywords: Duration recommendations are provided as a general guideline for therapy (IV or PO) with a goal of minimizing unintended consequences to the patient (e.g., precipitating C. difficile colitis, development of resistant pathogens, organ dysfunction). Patient-specific factors should influence duration decisions and transition to oral therapy.

  ---

• Aminoglycoside Dosing & Monitoring Guidelines (Adult)

  02/21/26

  Adult/Peds: Adult    

  Keywords: AMG, aminoglycoside, dosing, tobramycin, gentamicin, amikacin

  ---